Atlas Trials

Haplo-identical SCT for High Risk (HR) Hematologic Malignancies w/Post-Transplant In-Vivo T-cell Depletion

Clinical trial NCT02053545 · WITHDRAWN

Trial details

NCT number
NCT02053545
Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
LeukemiaLymphomaMDS
Start date
2013-12-01
Primary completion
2017-05-11
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.